Caris Life Sciences, Stock Probability of Future Stock Price Finishing Over 30.19
| CAI Stock | USD 30.19 1.10 3.52% |
Caris Life Target Price Odds to finish over 30.19
The tendency of Caris Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 30.19 | 90 days | 30.19 | about 6.3 |
Based on a normal probability distribution, the odds of Caris Life to move above the current price in 90 days from now is about 6.3 (This Caris Life Sciences, probability density function shows the probability of Caris Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Caris Life Sciences, has a beta of -0.2 suggesting as returns on the benchmark increase, returns on holding Caris Life are expected to decrease at a much lower rate. During a bear market, however, Caris Life Sciences, is likely to outperform the market. Additionally Caris Life Sciences, has an alpha of 0.4127, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Caris Life Price Density |
| Price |
Predictive Modules for Caris Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Caris Life Sciences,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Caris Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Caris Life is not an exception. The market had few large corrections towards the Caris Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Caris Life Sciences,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Caris Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | -0.2 | |
σ | Overall volatility | 1.66 | |
Ir | Information ratio | 0.08 |
Caris Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Caris Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Caris Life Sciences, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Caris Life Sciences, had very high historical volatility over the last 90 days | |
| Caris Life Sciences, has 60 M in debt with debt to equity (D/E) ratio of 2.41, meaning that the company heavily relies on borrowing funds for operations. Caris Life Sciences, has a current ratio of 0.44, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Caris to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 412.26 M. Reported Net Loss for the year was (281.89 M) with profit before taxes, overhead, and interest of 211.38 M. | |
| Caris Life Sciences, has about 38.81 M in cash with (245.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26. | |
| Roughly 48.0% of Caris Life shares are held by company insiders |
Caris Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Caris Stock often depends not only on the future outlook of the current and potential Caris Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Caris Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 277.9 M | |
| Shares Float | 48.1 M |
Caris Life Technical Analysis
Caris Life's future price can be derived by breaking down and analyzing its technical indicators over time. Caris Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Caris Life Sciences,. In general, you should focus on analyzing Caris Stock price patterns and their correlations with different microeconomic environments and drivers.
Caris Life Predictive Forecast Models
Caris Life's time-series forecasting models is one of many Caris Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Caris Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Caris Life Sciences,
Checking the ongoing alerts about Caris Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Caris Life Sciences, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Caris Life Sciences, had very high historical volatility over the last 90 days | |
| Caris Life Sciences, has 60 M in debt with debt to equity (D/E) ratio of 2.41, meaning that the company heavily relies on borrowing funds for operations. Caris Life Sciences, has a current ratio of 0.44, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Caris to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 412.26 M. Reported Net Loss for the year was (281.89 M) with profit before taxes, overhead, and interest of 211.38 M. | |
| Caris Life Sciences, has about 38.81 M in cash with (245.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26. | |
| Roughly 48.0% of Caris Life shares are held by company insiders |
Check out Caris Life Backtesting, Caris Life Valuation, Caris Life Correlation, Caris Life Hype Analysis, Caris Life Volatility, Caris Life History as well as Caris Life Performance. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences, is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.